Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TripSitter Clinic Ltd C.KETA

Alternate Symbol(s):  TSTTF

TripSitter Clinic Ltd. is a Canada-based company. The Company has no active business.

CSE:KETA - Post Discussion

View:
Post by yopmemama021 on Feb 14, 2022 7:23pm

KETA

Nice rip for $KETA.C today, up 22.5% closing at $0.49 

 

$KETA ’s app advocates for safe and responsible  use of psychedelics. their educational platform  has a growing reach as psychedelics attract more research, become less demonized and come closer to eventual legalization 

 

hoping to see this price action and  momentum continue with some news surrounding advancements in their expansions of global footprint 

 

Comment by StockHawk1 on Feb 15, 2022 4:40pm
Good post, I've also been interested in this company for a while.   Today $KETA saw high volume and an 8% dip but overall is still up 12.5% from last week's close. IMO considering how much $KETA's service improves upon current methods of providing ketamine treatment and the growing popularity of ketamine therapy it was still undervalued even at $0.49/share. I'm ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities